The score of neovascularization in the bone marrow measured with anti CD34 and CD15 of the endothelium is augmented in patients with MM compared with normal individuals, and it also correlates with the disease status, e.g., increases during evolution from MGUS to SMM/MM [154,155,156,157]. Here, CD34 is linked to Miyoshi myopathy.